Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

286 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of amino acids and parameters of bone metabolism with endothelial dysfunction and vasculopathic changes in limited systemic sclerosis.
Jud P, Meinitzer A, Strohmaier H, Arefnia B, Wimmer G, Obermayer-Pietsch B, Foris V, Kovacs G, Odler B, Moazedi-Fürst F, Brodmann M, Hafner F. Jud P, et al. Front Med (Lausanne). 2023 Jun 23;10:1193121. doi: 10.3389/fmed.2023.1193121. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37425312 Free PMC article.
Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)-A Randomized Controlled Trial.
Obermayer A, Tripolt NJ, Pferschy PN, Kojzar H, Aziz F, Müller A, Schauer M, Oulhaj A, Aberer F, Sourij C, Habisch H, Madl T, Pieber T, Obermayer-Pietsch B, Stadlbauer V, Sourij H. Obermayer A, et al. Diabetes Care. 2023 Feb 1;46(2):463-468. doi: 10.2337/dc22-1622. Diabetes Care. 2023. PMID: 36508320 Free PMC article. Clinical Trial.
SPIOMET4HEALTH-efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial.
Garcia-Beltran C, Malpique R, Andersen MS, Bas F, Bassols J, Darendeliler F, Díaz M, Dieris B, Fanelli F, Fröhlich-Reiterer E, Gambineri A, Glintborg D, López-Bermejo A, Mann C, Marin S, Obermayer-Pietsch B, Ødegård R, Ravn P, Reinehr T, Renzulli M, Salvador C, Singer V, Vanky E, Torres JV, Yildiz M, de Zegher F, Ibáñez L. Garcia-Beltran C, et al. Trials. 2023 Sep 15;24(1):589. doi: 10.1186/s13063-023-07593-6. Trials. 2023. PMID: 37715279 Free PMC article.
Corrigendum to "A time-course investigation of the human urinary excretion of the hydrogen sulfide biomarker trimethylsulfonium" [Environ. Toxicol. Pharmacol. 100 (2023) 104162].
Lajin B, Obermayer-Pietsch B, Somma R, Goessler W. Lajin B, et al. Among authors: obermayer pietsch b. Environ Toxicol Pharmacol. 2023 Nov;104:104296. doi: 10.1016/j.etap.2023.104296. Epub 2023 Oct 13. Environ Toxicol Pharmacol. 2023. PMID: 37839941 Free article. No abstract available.
PoCOsteo: generic novel platform for bone turnover marker measurement & monitoring.
Khashayar P, Lopes P, Ragaert P, Hoogenboom R, Latta D, Gransee R, Lenartowicz D, Biggs P, Etxebarria I, Luegger B, Obermayer-Pietsch B, Dimai HP, Vanfleteren J. Khashayar P, et al. Among authors: obermayer pietsch b. Anal Methods. 2024 May 13. doi: 10.1039/d4ay00207e. Online ahead of print. Anal Methods. 2024. PMID: 38738371
286 results